Variants in genes involved in DNA mismatch repair, particularly BRCA1/2, ATM, CHEK2, and NBN have been associated with an increased risk of developing PrCa in men with advanced/metastatic PrCa unselected for FH as well as in men with familial PrCa. The gene discussed is CHEK2; the disease is familial hyperaldosteronism.